Minerva Neurosciences, Inc. (NERV)
2.63
+0.21
(+8.68%)
USD |
NASDAQ |
Nov 09, 16:00
2.63
0.00 (0.00%)
After-Hours: 18:10
Minerva Neurosciences Gross Profit (Annual) : -0.0054M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.0054M |
| December 31, 2024 | -0.0225M |
| December 31, 2023 | -0.031M |
| December 31, 2022 | -0.0085M |
| December 31, 2021 | -0.1018M |
| December 31, 2020 | 41.00M |
| December 31, 2019 | -0.1615M |
| December 31, 2018 | -0.0175M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.0111M |
| December 31, 2016 | -0.0165M |
| December 31, 2015 | -0.0173M |
| December 31, 2014 | -0.0339M |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Heron Therapeutics, Inc. | 113.56M |
| Tonix Pharmaceuticals Holding Corp. | 4.542M |
| Karyopharm Therapeutics, Inc. | 139.82M |
| Corbus Pharmaceuticals Holdings, Inc. | -0.233M |
| Ocugen, Inc. | 2.024M |